跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HH-1-1
首页
药物
HH-1-1
HH-1-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
STEREOSELECTIVE PH RESPONSIVE PEPTIDE DENDRIMERS FOR NUCLEIC ACID TRANSFECTION
EP 4010354 C0
申请人: UNIV BERN
优先权: 2019
CN
EP
US
WO
4 件公开
COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF A DISEASE THAT IS ASSOCIATED WITH A WEAKENED INTESTINAL BARRIER
EP 4487864 A1
申请人: UNIV DER JOHANNES GUTENBERG UNIV MAINZ
优先权: 2023
EP
WO
2 件公开
Preventive or therapeutic agent for kidney disease
CN 1652761 A
申请人: KISSEI PHARMACEUTICAL
优先权: 2002
CN
2 件公开
Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system
US 8486945 B2
申请人: IVASHCHENKO ANDREY
优先权: 2007
US
2 件公开
Use of radix rhodiolae for preparing medicine for treating or preventing senile dementia
CN 1528387 A
申请人: AN LUFAN
优先权: 2003
CN
Method for preparing antihuman lymphocyte antibodies
CN 101570576 A
申请人: TAILIN WANG
优先权: 2009
CN
Anti-melanoma cytotoxic lymphocyte (CTL) multi-epitope peptide and application thereof
CN 102030829 B
申请人: UNIV PLA 2ND MILITARY MEDICAL
优先权: 2010
CN
Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
CN 108026134 A
申请人: UNIV BASEL
优先权: 2015
CN
靶向Smo蛋白的Hedgehog信号通路抑制剂及制备方法和用途
CN 113072607 B
申请人: 杭州医学院
优先权: 2021
CN
一种类孟买血型FUT1 236delG等位基因及其检测方法和应用
CN 113667673 B
申请人: 武汉血液中心
优先权: 2021
CN
第 1 / 2 页
上一页
下一页
药物
反馈